Skip to main content

Thermo Fisher Opens RNAi Lab in Colorado for Contract Services, R&D

NEW YORK (GenomeWeb News) — Thermo Fisher Scientific has opened an RNAi research and services lab in Lafayette, Colo., the company said today.
 
The lab will offer contract RNAi screening and analysis services, including high-throughput screening, along with services and research using the company’s bioreagents, robotics, and other instrument systems, the company said.
 
It will also develop new therapeutic technologies involving RNAi, Thermo said.
 
Thermo said the lab features its Dharmacon siRNA and miRNA libraries, as well as the BioImage and Cellomics high-content screening reagents and image-analysis instruments.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.